AI assistant
JOHNSON & JOHNSON — Director's Dealing 2017
Mar 7, 2017
29750_dirs_2017-03-07_b359852f-3ec8-4657-a53e-b0ddc97e8a86.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2017-03-03
Reporting Person: Duato Joaquin (Exec VP, WW Chair, Pharma)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-03 | Common Stock | M | 29158.0000 | $58.3300 | Acquired | 97694.0000 | Direct |
| 2017-03-03 | Common Stock | M | 20842.0000 | $61.7500 | Acquired | 118536.0000 | Direct |
| 2017-03-03 | Common Stock | S | 50000.0000 | $123.6228 | Disposed | 68536.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-03 | Employee Stock Options (Right to Buy) | $58.3300 | M | 29158.0000 | Disposed | 2019-02-08 | Common Stock (29158.0000) | Direct |
| 2017-03-03 | Employee Stock Options (Right to Buy) | $61.7500 | M | 20842.0000 | Disposed | 2018-02-10 | Common Stock (20842.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 570.0000 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $123.35 to $123.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2017).